Special Issue "New Insights into Targeted Therapy of Solid Tumors with Polymeric Nanoparticles"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".

Deadline for manuscript submissions: 30 June 2023 | Viewed by 240

Special Issue Editors

N. M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, Moscow 119334, Russia
Interests: nanomaterials; polymeric nanoparticles; anticancer therapy; solid tumor; drug delivery; protein corona; endothelial barrier; blood-brain barrier; enhanced permeability and retention
Russian National Research Medical University (RNRMU), The Chair of Medical Nanobiotechnologies, 117997, Ostrovityanova 1, Moscow, Russia
Interests: drug delivery; magnetic nanoparticles; imaging; theranosctics

Special Issue Information

Dear Colleagues,

Cancer is one of the leading causes of death across the globe. Worldwide statistics estimated nearly 20 million new cases and 10 million deaths in 2020. Modern medical treatment has led to the development of state-of-the-art therapeutic and diagnostic techniques and medicines. However, we still experience considerable limitations that impact the general cancer treatment landscape. Highly toxic anticancer treatment demands thorough approaches in drug application. Various polymer nanomaterials and nanoparticles have been extensively studied for drug delivery to solid tumors for over three decades. Today, along with novel mAbs, TK/checkpoint inhibitors, and cell-based treatment, various polymeric formulations have been applied in medicine, including anthracyclines, taxanes, alkaloids, etc., evidencing the applicability of this approach.

We are pleased to invite you to submit original research that describes novel research methods as well as original techniques in the field of the diagnosis and treatment of solid tumors through applying for nanoparticle-based medicines. Research areas may include (but are not limited to) the following: the application of polymeric nanoparticles for drug delivery as a diagnostic and treatment of solid tumors, including lipids, metals, and carbohydrate variations, among others.

 Authors are invited to submit their latest results. Original papers and reviews are welcome.

We look forward to receiving your contributions.

Dr. Nikita G. Yabbarov
Prof. Dr. Maxim A. Abakumov
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • nanomaterials
  • polymeric nanoparticles
  • anticancer therapy
  • solid tumor
  • drug delivery
  • protein corona
  • endothelial barrier
  • blood-brain barrier
  • enhanced permeability and retention

Published Papers

This special issue is now open for submission.
Back to TopTop